ReviewHeart failure reviews2026
Artificial intelligence and digital health in heart failure: advances in diagnosis, monitoring, phenotyping, and digital biomarkers.
Review in Heart failure reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Innovative strategies to reduce heart failure hospitalizations: insights from the ESC heart failure congress 2026.Heart failure reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) is an increasingly pressing public health concern, with projections suggesting its age-standardized prevalence will increase in coming decades. To accommodate the increasing burden that will be placed on patients and healthcare systems, applications of digital health technologies including artificial intelligence (AI) may improve aspects of HF care and monitoring. However, adoption of digital health solutions into HF clinical practice has been modest to date due to limited evidence of efficacy as well as technical, clinical implementation, and regulatory barriers. In this review, we discuss the state of the art in digital health technologies for HF, including applications of AI for medical image acquisition and processing, monitoring tools including remote patient management platforms and wearable devices, and phenotyping patients using actigraphy-enabled wearables. We further highlight potential solutions for barriers to the uptake of novel technologies and development of digital biomarkers in HF care and research. Together, this review underscores the potential for digital health and AI tools to improve HF outcomes and prepares stakeholders to implement these technologies effectively.
Indexed as
Identifiers
41712043What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.